Drug Patent Expirations for the Week of February 4, 2024

NATESTO (testosterone) Acerus Patent: 8,784,869 Expiration: Feb 4, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pate…


New patent expiration for Am Regent drug INJECTAFER

Annual Drug Patent Expirations for INJECTAFER Injectafer is a drug marketed by Am Regent and is included in one NDA. It is available from one supplier. There are ten patents…
The post New patent expiration for Am Regent drug INJECTAFER appeared first o…


Biotechblog